Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
CRT 2019: ABSORB II Trial
Author(s): Javier Escaned Added: 5 years ago
Prof Javier Escaned (Hospital Clinico San Carlos, Madrid, ES) discusses the long term effect of bioresorbable scaffolds and metallic drug eluting stents (DES) on human coronary hemodynamics, following the results from the latest ABSORB II randomised trial. Filmed on site at CRT 2019 by Radcliffe Cardiology Questions: 1. Why did you conduct this research? 2. Which devices were followed and how… View more

Intervention
Overview of Quantitative Flow Ratio and Optical Flow Ratio in the Assessment of Intermediate Coronary Lesions
Author(s): Jelmer Westra , Shengxian Tu Added: 3 years ago
Physiological lesion assessment is recommended for the identification of intermediate coronary lesions that might benefit from percutaneous coronary intervention (PCI).1 The quantitative flow ratio (QFR) was developed to derive coronary physiology from angiographic images, whereas the optical flow ratio (OFR) is a more recent approach for the rapid and automated assessment of coronary physiology… View more

Intervention
Author(s): Morton J Kern , Katherine M Yu Added: 3 years ago
Coronary artery disease (CAD), the most common cause of morbidity and mortality in the US, is frequently identified by coronary angiography. Decisions for treatment are often based on angiography alone, absent other clinical indicators for intervention. However, by angiography alone, conventional wisdom has suggested that a coronary stenosis is significant if there is at least a 50 % diameter… View more

Prevention & Chronic Conditions
Mechanical Circulatory Support for Complex High-risk PCI
Author(s): Alexander G Truesdell , Rhian E Davies , Moemen Eltelbany , et al Added: 1 year ago

Heart Failure

Intervention
Webinar Series
Author(s): José M de la Torre Hernández , Hee Hwa Ho , , et al Added: 2 years ago
Left Main Coronary Artery (LMCA) intervention is challengingto the operator due to a wide array of factors as compared to treating other stenosis elsewhere in the coronary tree. Complications arising from hemodynamic instability, lack of proximal reference angiographically and lesion preparation due to a higher rate of atherosclerosis make LM Coronary Artery Disease (CAD) by far the most complex… View more

MI/ACS

Intervention
Invasive Evaluation for Coronary Vasospasm
Author(s): Jingwen Huang , Rebecca Steinberg , Matthew J Brown , et al Added: 10 months ago

MI/ACS

Intervention
Job title: Head of Hemodynamics and Interventional Cardiology
Prof Jose M de la Torreis an interventional cardiologist and Head of the Hemodynamics and Interventional Department of the Marques de Valdecilla University of Santander, ES. Prof Jose M de la Torre is member of the scientific committee of the Spanish Society of Cardiology and is fellow of the European Society of Cardiology. Former associate director of the Trans Catheter Therapeutics Meeting… View more
Author(s): Ahmed M Alabbady , Ahmed S Abdul-Al , Kimberly A Skelding Added: 3 years ago
The introduction of percutaneous coronary angioplasty in 1977 by Dr Andreas Grüntzig1 was one of the most remarkable achievements in the cardiology realm, opening the door to numerous advancements in percutaneous coronary interventions (PCIs). Due to advances in PCI techniques over the past four decades, catheters along with four generations of coronary stents have dramatically changed the… View more

Intervention
The Role of Hemodynamic Support in High-risk Percutaneous Coronary Intervention
Author(s): Charles Simonton , Craig Thompson , Jason R Wollmuth , et al Added: 3 years ago
Coronary artery disease (CAD) is a leading cause of morbidity and mortality globally, despite advances in medical and preventive therapy. It is estimated that 18.2 million adults in the US have CAD, with 720,000 Americans projected to have a first hospitalization for MI or CAD death this year.1 Treatment of patients with symptomatic CAD includes guideline-directed medical therapy and coronary… View more

Intervention
Navin K Kapur
Job title: Associate Professor
Dr Navin K Kapur, MD, FAHA, FACC, FSCAI is Executive Director, The CardioVascular Center for Research and Innovation (CVCRI); Director, Acute Mechanical Circulatory Support Program; Director, Interventional Research Laboratories; Director of Cardiac Biology Research Center, Molecular Cardiology Research Institute (MCRI); Associate Professor, Tufts University School of Medicine. Dr Kapur's… View more